Full text is available at the source.
Metabolic complications and their mechanisms in patients with craniopharyngioma
Metabolic problems and how they develop in patients with craniopharyngioma
AI simplified
Abstract
Patients with craniopharyngioma frequently experience rapid weight gain leading to morbid hypothalamic obesity.
- Hypothalamic obesity is linked to hypothalamic syndrome, which includes various neuroendocrine and behavioral issues.
- Long-term outcomes for patients with hypothalamic syndrome may be worsened by increased risks of metabolic syndrome and cardiovascular problems.
- Treatment options for hypothalamic syndrome include dextro-amphetamines, GLP-1 receptor agonists, and bariatric surgery, though the latter raises ethical concerns for minors.
- A recently published algorithm aims to provide personalized treatment strategies for managing hypothalamic syndrome.
- There is a need for hypothalamus-sparing treatment strategies and research into new therapeutic agents.
AI simplified